Mexico Trauma Devices Market Overview, 2031

Key Insights

• Mexico faces a substantial and growing trauma burden, driven by a high incidence of road traffic accidents, workplace injuries, and an aging population increasingly susceptible to fractures. Traffic-related injuries alone account for a significant share of trauma cases, with over 720,000 traffic accidents recorded annually, highlighting the persistent demand for effective trauma care solutions across the country.
• The trauma fixation market in Mexico is experiencing robust growth, supported by government initiatives to modernize healthcare infrastructure and expand access to specialized trauma care. The establishment of dedicated trauma centers and the upgrading of existing hospital facilities are creating a favorable environment for the adoption of advanced trauma devices and technologies.
• The Mexican orthopedic and trauma device landscape is characterized by intense competition between established multinational corporations and emerging domestic players. Strategic acquisitions, such as Poly Medicure's acquisition of Citieffe Group, are reshaping the competitive dynamics and expanding the product portfolios available to Mexican healthcare providers.

Market Outlook

• According to the research report, "Mexico Trauma Devices Market Outlook, 2031," published by Bonafide Research, the Mexico Trauma Devices Market is expected to reach a market size of more than USD 752.74 Million by 2031.
• The Mexico Trauma Fixation Market is experiencing steady growth, driven by rising incidences of road accidents, sports injuries, and an aging population susceptible to osteoporotic fractures. Government initiatives to improve healthcare infrastructure and access are facilitating increased adoption of advanced trauma fixation devices, such as internal and external fixators, plates, and screws.
• International and domestic manufacturers are competing in the market, with innovation focused on minimally invasive procedures and biocompatible materials. There is a noticeable shift toward minimally invasive fixation procedures, supported by advancements in implant materials such as titanium and bioabsorbable polymers. The market is also seeing heightened adoption of digital technologies, such as 3D-printed implants and surgical navigation systems, reflecting a broader trend toward personalized medicine and improved surgical precision in trauma care.
• The market is projected to grow at a CAGR of around 5-7% through 2028, with orthopedics and trauma care centers constituting key end users. The Internal Fixation Devices segment is expected to be the highest contributor to the market, with $255.1 million in 2022, anticipated to reach $549.9 million by 2032. However, cost constraints, limited awareness in rural areas, and competition from low-cost generic products pose challenges to market expansion.

Policies

• The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is the regulatory authority responsible for medical devices in Mexico, equivalent to the U.S. FDA. COFEPRIS governs device classification, facility compliance, market authorization, and post-market surveillance.
• All medical devices must obtain a sanitary registration from COFEPRIS before they can be marketed in Mexico. Standard Registration requires a full technical dossier submitted directly to COFEPRIS, including detailed device descriptions, design specifications, clinical evidence supporting safety and efficacy, quality system documentation, and Spanish-language labeling.
• Effective September 1, 2025, COFEPRIS launched a fast-track registration route for devices that already hold approval from an IMDRF or MDSAP-recognized authority, including the FDA. This update aims to reduce administrative burdens and make the authorization process more efficient while maintaining verification that each product meets Mexican sanitary standards.
• All medical devices must comply with labeling requirements found in NOM-137-SSA1-2008 (recently updated to NOM-137-SSA1-2025), with labeling and Instructions for Use required to be in Spanish.

Trauma Burden & Treatment Statistics

• Traffic-related Injuries and fall collectively accounted for approximately 72.7% of the Mexico Trauma Care Centers market in 2022, with Traffic-related Injuries constituting around 41.8% share. Traffic-related Injuries and fall are expected to witness significant growth at CAGRs of 3.21% and 2.84%, respectively, during the forecast period.
• In 2024, Mexico recorded 720,429 traffic accidents, of which 86,124 involved motorcycles in urban and suburban areas. During 2024, Puebla reported 8,900 work accidents, representing 3.7% of the 239,800 incidents recorded nationally.

Industry News

• In October 2025, CareFix Medical announced its participation as a key exhibitor at the prestigious FEMECOT 2025 Congress in Mexico, where it showcased its comprehensive portfolio of advanced orthopedic solutions from October 21 to 25, 2025, at Expo Guadalajara in Jalisco, Mexico.
• In September 2025, Poly Medicure Ltd announced the full acquisition of Italy-based Citieffe Group at an enterprise value of ₹324 crore (EUR 31 million). With Citieffe's presence in the United States, Italy, and Mexico, the acquisition provides Poly Medicure with a strategic entry into the global orthopaedics market, particularly in the trauma and extremities segment, one of the fastest-growing and most resilient areas within orthopaedics.

Segment Analysis

Mexico Trauma Devices Market By Product Type
• Internal fixation devices are used in approximately 85,000-100,000 fracture fixation procedures annually in Mexico, including plates, screws, intramedullary nails, and locking systems. Major public and private hospitals typically maintain inventories of 15-25 plating and nailing systems to support trauma care. Orthopedic surgeons use an average of 5-10 fixation components per surgery, while revision procedures related to implant failure, malunion, or non-union account for 4,000-7,000 cases annually.
• External fixation devices support approximately 10,000-15,000 trauma procedures annually, particularly for open fractures, polytrauma cases, and temporary stabilization. Major trauma centers commonly stock 20-40 external fixation sets for emergency use. Procedures generally require 4-8 fixation pins per patient, and external fixation frequently serves as an interim treatment before definitive fracture reconstruction.
• Orthobiologics and synthetic bone grafts are utilized in approximately 18,000-25,000 trauma and reconstructive procedures annually in Mexico. Bone graft substitutes are commonly used in fracture non-unions, bone defects, and revision surgeries, with average graft volumes ranging from 5-20 cc per procedure. Large orthopedic centers may perform 300-800 graft-assisted trauma surgeries per year, reflecting growing adoption in complex trauma management.

Mexico Trauma Devices Market By Surgical Site / Anatomical Location
• Upper extremity trauma devices are used in approximately 35,000-45,000 surgical procedures annually for fractures involving the wrist, hand, forearm, clavicle, and humerus. Distal radius fractures account for a significant share of surgical interventions, generating more than 12,000 procedures annually. Average hospitalization following upper-limb trauma surgery ranges from 1-3 days, with rehabilitation programs often lasting 4-8 weeks.
• Lower extremity trauma devices support approximately 70,000-90,000 fracture fixation procedures annually in Mexico. Femur, tibia, ankle, and hip fractures account for a substantial proportion of orthopedic trauma admissions, exceeding 100,000 hospitalizations annually. Patients undergoing major lower-extremity fixation typically require 4-9 days of hospitalization, followed by rehabilitation periods extending from 2-6 months.
• Pelvic trauma devices are utilized in approximately 5,000-8,000 surgical interventions annually. Pelvic fractures generate estimated 15,000-20,000 trauma admissions each year, often resulting from high-energy incidents such as motor vehicle accidents. Surgical cases commonly require 7-14 days of hospitalization, with post-operative rehabilitation frequently extending beyond 12 weeks.

Mexico Trauma Devices Market By End User
• Hospitals represent the primary setting for trauma device utilization in Mexico, with more than 4,500 public and private hospitals nationwide. These facilities perform approximately 150,000-200,000 orthopedic trauma surgeries annually and manage over 250,000 trauma-related admissions each year. Large trauma hospitals may conduct 2,000-5,000 orthopedic trauma procedures annually and maintain extensive implant inventories.
• Ambulatory Surgical Centers perform approximately 15,000-25,000 orthopedic trauma-related procedures annually, mainly involving minor fracture repairs, hardware removals, and outpatient trauma interventions. Individual centers typically conduct 800-2,000 orthopedic procedures per year, with same-day discharge being standard for most patients. Many ASCs maintain dedicated trauma instrument inventories and imaging capabilities for outpatient care.
• Orthopedic clinics manage approximately 500,000-700,000 trauma-related consultations annually throughout Mexico. These facilities provide fracture assessments, post-operative monitoring, rehabilitation coordination, and implant follow-up services. Individual orthopedic specialists commonly evaluate 25-50 trauma patients per week, supporting long-term recovery and outpatient trauma management.

Mexico Trauma Devices Market By Material Type
• Stainless steel implants are utilized in approximately 40,000-60,000 trauma fixation procedures annually in Mexico. They remain widely used for standard plating systems, screws, and cost-sensitive trauma treatments. Large public hospitals procure thousands of stainless steel fixation components each year, and implant retention commonly extends beyond 5 years in routine trauma cases.
• Titanium and titanium alloy implants support approximately 70,000-90,000 trauma surgeries annually and are extensively used in long-bone, pelvic, and cranio-maxillofacial fracture fixation. Major orthopedic centers routinely stock multiple titanium implant systems for advanced trauma care. Long-term implant retention often exceeds 10 years, reducing the need for secondary removal procedures.
• Bioabsorbable materials are used in approximately 4,000-8,000 trauma procedures annually, particularly in pediatric, sports related, and cranio maxillofacial applications. These implants typically degrade within 12-36 months, eliminating the need for removal in many cases. Specialized orthopedic centers increasingly utilize bioabsorbable fixation systems for selected fracture indications.


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Trauma Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Internal Fixation Devices
• External Fixation Devices
• Orthobiologics & Synthetic Bone Grafts
• Trauma Surgical Instruments & Accessories

By Surgical Site / Anatomical Location
• Upper Extremity Trauma Devices
• Lower Extremity Trauma Devices
• Pelvic Trauma Devices
• Cranio-Maxillofacial Trauma Devices

By End User
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Orthopedic Clinics

By Material Type
• Stainless Steel
• Titanium & Titanium Alloys
• Bioabsorbable Materials
• Other Materials